Pediatric Second-Degree Burn Outcomes With and Without Hemoglobin Spray

A 2023-2024 retrospective study from a tertiary burn unit compares healing outcomes for pediatric patients. Patients treated with 99.9% purified hemoglobin spray had significantly shorter hospital stays and epithelialization times. The data includes demographics, burn characteristics, dressing counts, and follow-up assessments for pruritus and scarring.

Use Cases

• Compare hospital length of stay based on treatment type.
• Analyze the relationship between burn characteristics and epithelialization time.
• Model the risk of long-term complications like hypertrophic scarring based on treatment.
• Evaluate the effectiveness of adjunctive therapies on post-discharge pruritus.

Strengths

• Includes follow-up assessments at 3 and 6 months post-discharge for long-term outcomes.
• Reports specific, statistically significant risk reductions (e.g., 94.0% for pigmentation defects).
• Focuses on a specific, clinically relevant population: pediatric patients with second-degree burns.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal and institutional bias inherent to a single tertiary burn unit study.

Provenance

Source

Erol Can Kulice via figshare.

Collection Method

Retrospective data collection from a tertiary burn unit.

Time Range

December 1, 2023, to December 1, 2024.

Freshness

Last updated 2026-05-12 14:56:20; freshness should be verified.